Company Filing History:
Years Active: 2001-2008
Title: The Innovative Contributions of Edward Leung
Introduction
Edward Leung is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of medicinal chemistry, particularly in the synthesis of adenosine derivatives. With a total of 5 patents to his name, Leung's work has implications for pain management and drug development.
Latest Patents
Among his latest patents is the "Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs." This patent provides a method for synthesizing aralkyloxyadenosine or alkoxyadenosine by protecting hydroxyl sugar groups, producing a protected halogenated adenosine, which is then alkoxylated. The final step involves deprotecting the hydroxyl sugar groups to yield the desired compounds. Another significant patent is the "Method for treating pain in humans," which relates to Compound T62 and its pharmaceutically acceptable salts. This invention focuses on enhancing allosteric adenosine A receptor activity, offering potential treatments for various pain types, including persistent chemical pain and migraines.
Career Highlights
Edward Leung has worked with King Pharmaceuticals Research and Development, Inc., where he contributed to innovative research in pharmaceuticals. His expertise in medicinal chemistry has been instrumental in advancing the development of new therapeutic agents.
Collaborations
Leung has collaborated with notable colleagues such as Pier Giovanni Baraldi and Pier Andrea Borea. These partnerships have fostered a collaborative environment that enhances the research and development of new medicinal compounds.
Conclusion
Edward Leung's contributions to the field of medicinal chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of effective treatments for pain management and other medical applications.